Skip to content

SARS-CoV-2 Nucleocapsid Antibody, Serum/Plasma (Qualitative)

Published: August 9, 2026Updated: August 16, 2026

This test detects antibodies in your blood that may have developed in response to the SARS-CoV-2 virus, which causes COVID-19. Antibodies can appear after infection or vaccination.

Quick summary

["This test helps determine if your immune system has recognized past or current exposure to COVID-19."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
95411-5
Short code
SARS-CoV-2 NAb Ser Ql pVNT
Synonyms
SARS-CoV-2 NAb Ser Ql pVNT
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
pvnt
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Does This Test Measure?

The test looks for antibodies specifically targeting the nucleocapsid protein of the SARS-CoV-2 virus. These antibodies are part of your immune response and can indicate whether you’ve been exposed to the virus, even if you didn’t experience symptoms or were previously vaccinated.

Why Might You Need This Test?

Healthcare providers may order this test to confirm past infection, assess immunity after vaccination, evaluate exposure risk in certain settings (e.g., healthcare workers, travelers), or investigate unexplained symptoms suggestive of COVID-19.

How Is the Sample Collected?

A blood sample is drawn from a vein, usually in your arm. The blood is then processed to separate serum or plasma for testing.

What Are the Possible Results?

The result is qualitative (positive or negative). A positive result suggests the presence of antibodies, indicating potential past infection or immune response. A negative result means no detectable antibodies were found at this time.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: This test is primarily used to identify immune response to SARS-CoV-2, aiding in diagnosis, monitoring, or research. However, it cannot distinguish between infection and vaccination alone. Results should be interpreted alongside clinical context, symptoms, and other diagnostic findings.

Short name

SARS-CoV-2 N Antibody Screen

Frequently asked questions

Can this test tell me if I had COVID-19 recently?
No, this test measures antibodies that develop after infection or vaccination, which may take several weeks to appear. A negative result does not rule out recent infection, especially if tested too early.
What if my test is positive but I never had symptoms?
A positive result could mean you had a mild or asymptomatic infection, or you may have been exposed to the virus without developing symptoms. Antibodies can also appear after vaccination.
Does this test replace a COVID-19 PCR test?
No, this test is not a replacement for PCR testing, which directly detects the virus. Antibody tests are used differently, such as for screening or assessing immunity, and may not detect current infection.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy